Sana Biotechnology (SANA)
(Delayed Data from NSDQ)
$5.09 USD
-0.13 (-2.49%)
Updated Jul 5, 2024 04:00 PM ET
After-Market: $5.10 +0.01 (0.20%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth A Momentum C VGM
Cash flow Statements
Fiscal Year End for Sana Biotechnology, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -283.26 | -269.48 | -355.93 | -285.31 | -130.78 |
Depreciation/Amortization & Depletion | 24.56 | 15.63 | 11.07 | 5.92 | 1.83 |
Net Change from Assets/Liabilities | 18.61 | 7.54 | 9.80 | 6.16 | 10.53 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -13.50 | -43.74 | 84.00 | 135.25 | 32.92 |
Net Cash From Operating Activities | -253.58 | -290.05 | -251.05 | -137.98 | -85.50 |
Property & Equipment | -20.03 | -20.88 | -29.86 | -23.87 | -26.12 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | -3.20 |
Investments | 192.04 | 231.44 | -211.36 | -228.69 | -58.54 |
Other Investing Activities | 0.00 | 0.00 | -4.57 | 0.00 | 0.00 |
Net Cash from Investing Activities | 172.01 | 210.56 | -245.80 | -252.56 | -87.86 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 31.65 | 4.91 | 631.75 | 435.69 | 223.74 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
Net Cash from Financing Activities | 31.65 | 4.91 | 631.75 | 435.69 | 223.73 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -49.92 | -74.58 | 134.90 | 45.14 | 50.36 |
Cash at Beginning of Period | 187.27 | 261.85 | 126.95 | 81.81 | 31.45 |
Cash at End of Period | 137.35 | 187.27 | 261.85 | 126.95 | 81.81 |
Diluted Net EPS | -1.46 | -1.43 | -2.14 | -21.92 | NA |
Fiscal Year End for Sana Biotechnology, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -107.48 | -283.26 | -195.14 | -196.12 | -82.12 |
Depreciation/Amortization & Depletion | 3.75 | 24.56 | 13.29 | 8.79 | 4.35 |
Net Change from Assets/Liabilities | -7.46 | 18.61 | 8.37 | 3.19 | -10.81 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 45.56 | -13.50 | -28.15 | 46.07 | 9.31 |
Net Cash From Operating Activities | -65.63 | -253.58 | -201.62 | -138.07 | -79.27 |
Property & Equipment | -15.85 | -20.03 | -5.99 | -3.75 | -2.18 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -61.38 | 192.04 | 162.69 | 109.11 | 64.90 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -77.23 | 172.01 | 156.70 | 105.35 | 62.73 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 186.40 | 31.65 | 29.93 | 29.74 | 0.24 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 186.40 | 31.65 | 29.93 | 29.74 | 0.24 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 43.54 | -49.92 | -14.99 | -2.98 | -16.31 |
Cash at Beginning of Period | 137.35 | 187.27 | 187.27 | 187.27 | 187.27 |
Cash at End of Period | 180.89 | 137.35 | 172.28 | 184.30 | 170.96 |
Diluted Net EPS | -0.49 | -0.44 | 0.00 | -0.59 | -0.43 |